-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board; Ad hoc Subcommittee on Global Cancer Research.
Open: September 8, 2014, 6:00 p.m. to 7:30 p.m.
Agenda: Discussion on Global Cancer Research.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814.
Contact Person: Dr. Edward Trimble, MD, MPH, Executive Secretary, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276-5796, trimblet@dct.nci.nih.gov.
Name of Committee: National Cancer Advisory Board.
Open: September 9, 2014, 9:00 a.m. to 5:00 p.m.
Agenda: Program reports and presentations; business of the Board.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 9609 Start Printed Page 47151Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-6340, grayp@dea.nci.nih.gov.
Name of Committee: National Cancer Advisory Board.
Open: September 10, 2014, 9:00 a.m. to 10:00 a.m.
Agenda: Program reports and presentations; business of the Board.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Closed: September 10, 2014, 10:15 a.m. to 12:00 p.m.
Agenda: Grant application review.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-6340, grayp@dea.nci.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/ where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Start SignatureDated: August 6, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-18995 Filed 8-11-14; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 08/12/2014
- Department:
- Health and Human Services Department
- Entry Type:
- Notice
- Document Number:
- 2014-18995
- Pages:
- 47150-47151 (2 pages)
- PDF File:
- 2014-18995.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute